Fetal antiepileptic drug exposure: Motor, adaptive, and emotional/behavioral functioning at age 3years

Morris J. Cohen, Kimford J. Meador, Nancy Browning, Gus A. Baker, Jill Clayton-Smith, Laura A. Kalayjian, Andres M Kanner, Joyce D. Liporace, Page B. Pennell, Michael Privitera, David W. Loring

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

The Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) Study is an ongoing prospective observational multicenter study in the United States and United Kingdom that enrolled pregnant women with epilepsy on antiepileptic drug (AED) monotherapy from 1999 to 2004. The study seeks to determine if differential long-term neurodevelopmental effects exist across four commonly used AEDs (carbamazepine, lamotrigine, phenytoin, valproate). In this article, we examine fetal AED exposure effects on motor, adaptive, and emotional/behavioral functioning in 229 children who completed at least one of these tests at 3. years of age. Adjusted mean scores for the four AED groups were in the low average to average range for motor functioning, parental ratings of adaptive functioning, and parental ratings of emotional/behavioral functioning. A significant dose-related performance decline in motor functioning was seen for both valproate and carbamazepine. A significant dose-related performance decline in parental ratings of adaptive functioning was also seen for valproate, with a marginal performance decline evident for carbamazepine. Further, parents endorsed a significant decline in social skills for valproate that was dose related. Finally, on the basis of parent ratings of attention span and hyperactivity, children of mothers who took valproate during their pregnancy appear to be at a significantly greater risk for a future diagnosis of attention-deficit/hyperactivity disorder. Additional research is needed to confirm these findings, examine risks of other AEDs, define the risks in the neonate associated with AEDs for treatment of seizures, and determine the underlying mechanisms of adverse AED effects on the immature brain.

Original languageEnglish (US)
Pages (from-to)240-246
Number of pages7
JournalEpilepsy and Behavior
Volume22
Issue number2
DOIs
StatePublished - Oct 2011
Externally publishedYes

Fingerprint

Valproic Acid
Anticonvulsants
Carbamazepine
Phenytoin
Attention Deficit Disorder with Hyperactivity
Multicenter Studies
Observational Studies
Pregnant Women
Epilepsy
Seizures
Parents
Mothers
Newborn Infant
Pregnancy
Brain
Research

Keywords

  • Antiepileptic drugs
  • Behavioral neurology
  • Carbamazepine
  • Child development
  • Epilepsy
  • Pregnancy
  • Valproate

ASJC Scopus subject areas

  • Clinical Neurology
  • Behavioral Neuroscience
  • Neurology

Cite this

Cohen, M. J., Meador, K. J., Browning, N., Baker, G. A., Clayton-Smith, J., Kalayjian, L. A., ... Loring, D. W. (2011). Fetal antiepileptic drug exposure: Motor, adaptive, and emotional/behavioral functioning at age 3years. Epilepsy and Behavior, 22(2), 240-246. https://doi.org/10.1016/j.yebeh.2011.06.014

Fetal antiepileptic drug exposure : Motor, adaptive, and emotional/behavioral functioning at age 3years. / Cohen, Morris J.; Meador, Kimford J.; Browning, Nancy; Baker, Gus A.; Clayton-Smith, Jill; Kalayjian, Laura A.; Kanner, Andres M; Liporace, Joyce D.; Pennell, Page B.; Privitera, Michael; Loring, David W.

In: Epilepsy and Behavior, Vol. 22, No. 2, 10.2011, p. 240-246.

Research output: Contribution to journalArticle

Cohen, MJ, Meador, KJ, Browning, N, Baker, GA, Clayton-Smith, J, Kalayjian, LA, Kanner, AM, Liporace, JD, Pennell, PB, Privitera, M & Loring, DW 2011, 'Fetal antiepileptic drug exposure: Motor, adaptive, and emotional/behavioral functioning at age 3years', Epilepsy and Behavior, vol. 22, no. 2, pp. 240-246. https://doi.org/10.1016/j.yebeh.2011.06.014
Cohen, Morris J. ; Meador, Kimford J. ; Browning, Nancy ; Baker, Gus A. ; Clayton-Smith, Jill ; Kalayjian, Laura A. ; Kanner, Andres M ; Liporace, Joyce D. ; Pennell, Page B. ; Privitera, Michael ; Loring, David W. / Fetal antiepileptic drug exposure : Motor, adaptive, and emotional/behavioral functioning at age 3years. In: Epilepsy and Behavior. 2011 ; Vol. 22, No. 2. pp. 240-246.
@article{2536a5a9eda145449a7c0355124c8396,
title = "Fetal antiepileptic drug exposure: Motor, adaptive, and emotional/behavioral functioning at age 3years",
abstract = "The Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) Study is an ongoing prospective observational multicenter study in the United States and United Kingdom that enrolled pregnant women with epilepsy on antiepileptic drug (AED) monotherapy from 1999 to 2004. The study seeks to determine if differential long-term neurodevelopmental effects exist across four commonly used AEDs (carbamazepine, lamotrigine, phenytoin, valproate). In this article, we examine fetal AED exposure effects on motor, adaptive, and emotional/behavioral functioning in 229 children who completed at least one of these tests at 3. years of age. Adjusted mean scores for the four AED groups were in the low average to average range for motor functioning, parental ratings of adaptive functioning, and parental ratings of emotional/behavioral functioning. A significant dose-related performance decline in motor functioning was seen for both valproate and carbamazepine. A significant dose-related performance decline in parental ratings of adaptive functioning was also seen for valproate, with a marginal performance decline evident for carbamazepine. Further, parents endorsed a significant decline in social skills for valproate that was dose related. Finally, on the basis of parent ratings of attention span and hyperactivity, children of mothers who took valproate during their pregnancy appear to be at a significantly greater risk for a future diagnosis of attention-deficit/hyperactivity disorder. Additional research is needed to confirm these findings, examine risks of other AEDs, define the risks in the neonate associated with AEDs for treatment of seizures, and determine the underlying mechanisms of adverse AED effects on the immature brain.",
keywords = "Antiepileptic drugs, Behavioral neurology, Carbamazepine, Child development, Epilepsy, Pregnancy, Valproate",
author = "Cohen, {Morris J.} and Meador, {Kimford J.} and Nancy Browning and Baker, {Gus A.} and Jill Clayton-Smith and Kalayjian, {Laura A.} and Kanner, {Andres M} and Liporace, {Joyce D.} and Pennell, {Page B.} and Michael Privitera and Loring, {David W.}",
year = "2011",
month = "10",
doi = "10.1016/j.yebeh.2011.06.014",
language = "English (US)",
volume = "22",
pages = "240--246",
journal = "Epilepsy and Behavior",
issn = "1525-5050",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Fetal antiepileptic drug exposure

T2 - Motor, adaptive, and emotional/behavioral functioning at age 3years

AU - Cohen, Morris J.

AU - Meador, Kimford J.

AU - Browning, Nancy

AU - Baker, Gus A.

AU - Clayton-Smith, Jill

AU - Kalayjian, Laura A.

AU - Kanner, Andres M

AU - Liporace, Joyce D.

AU - Pennell, Page B.

AU - Privitera, Michael

AU - Loring, David W.

PY - 2011/10

Y1 - 2011/10

N2 - The Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) Study is an ongoing prospective observational multicenter study in the United States and United Kingdom that enrolled pregnant women with epilepsy on antiepileptic drug (AED) monotherapy from 1999 to 2004. The study seeks to determine if differential long-term neurodevelopmental effects exist across four commonly used AEDs (carbamazepine, lamotrigine, phenytoin, valproate). In this article, we examine fetal AED exposure effects on motor, adaptive, and emotional/behavioral functioning in 229 children who completed at least one of these tests at 3. years of age. Adjusted mean scores for the four AED groups were in the low average to average range for motor functioning, parental ratings of adaptive functioning, and parental ratings of emotional/behavioral functioning. A significant dose-related performance decline in motor functioning was seen for both valproate and carbamazepine. A significant dose-related performance decline in parental ratings of adaptive functioning was also seen for valproate, with a marginal performance decline evident for carbamazepine. Further, parents endorsed a significant decline in social skills for valproate that was dose related. Finally, on the basis of parent ratings of attention span and hyperactivity, children of mothers who took valproate during their pregnancy appear to be at a significantly greater risk for a future diagnosis of attention-deficit/hyperactivity disorder. Additional research is needed to confirm these findings, examine risks of other AEDs, define the risks in the neonate associated with AEDs for treatment of seizures, and determine the underlying mechanisms of adverse AED effects on the immature brain.

AB - The Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) Study is an ongoing prospective observational multicenter study in the United States and United Kingdom that enrolled pregnant women with epilepsy on antiepileptic drug (AED) monotherapy from 1999 to 2004. The study seeks to determine if differential long-term neurodevelopmental effects exist across four commonly used AEDs (carbamazepine, lamotrigine, phenytoin, valproate). In this article, we examine fetal AED exposure effects on motor, adaptive, and emotional/behavioral functioning in 229 children who completed at least one of these tests at 3. years of age. Adjusted mean scores for the four AED groups were in the low average to average range for motor functioning, parental ratings of adaptive functioning, and parental ratings of emotional/behavioral functioning. A significant dose-related performance decline in motor functioning was seen for both valproate and carbamazepine. A significant dose-related performance decline in parental ratings of adaptive functioning was also seen for valproate, with a marginal performance decline evident for carbamazepine. Further, parents endorsed a significant decline in social skills for valproate that was dose related. Finally, on the basis of parent ratings of attention span and hyperactivity, children of mothers who took valproate during their pregnancy appear to be at a significantly greater risk for a future diagnosis of attention-deficit/hyperactivity disorder. Additional research is needed to confirm these findings, examine risks of other AEDs, define the risks in the neonate associated with AEDs for treatment of seizures, and determine the underlying mechanisms of adverse AED effects on the immature brain.

KW - Antiepileptic drugs

KW - Behavioral neurology

KW - Carbamazepine

KW - Child development

KW - Epilepsy

KW - Pregnancy

KW - Valproate

UR - http://www.scopus.com/inward/record.url?scp=80053386087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053386087&partnerID=8YFLogxK

U2 - 10.1016/j.yebeh.2011.06.014

DO - 10.1016/j.yebeh.2011.06.014

M3 - Article

C2 - 21783425

AN - SCOPUS:80053386087

VL - 22

SP - 240

EP - 246

JO - Epilepsy and Behavior

JF - Epilepsy and Behavior

SN - 1525-5050

IS - 2

ER -